To meet the President's challenge, I ordered HHS to launch an unprecedented all agency effort to identify all cause of autism,

including toxic and pharmaceutical exposures.

President Trump's urging NIH, FDA, CDC, and CMS

are turning over every stone to identify the ideology

of the autism epidemic and how patients and parents can prevent and reverse

this alarming trend.

We have broken down the traditional silos that have long separated the agencies, and we have

fast-tracked research and guidance.

Historically, NIH has focused almost solely on politically safe and entirely fruitless research about the genetic drivers of autism.

And that would be like studying the genetic drivers of lung cancer without looking at cigarettes.

And that's what NIH has been doing for 20 years.

As a result, we don't have an answer to this critical question,

despite the cataclysmic impact of the epidemic on our nation's children.

We are now replacing the institutional culture of politicized science and corruption with evidence-based medicine. NIH research teams are currently testing multiple hypotheses with no area off-limits.

We promise transparency as we uncover the potential causes and treatments,

and we will notify the public regularly of our progress. Today, we are announcing two important findings from our autism work that are vital for parents to know as they make these decisions.

First, HHS will act on acetametaphim.

The FDA is responding to clinical and laboratory studies and suggests a potential association between

acetametaphine used during pregnancy and adverse neurodevelopmental outcomes, including later

diagnosis for ADHD and autism. Scientists have proposed biological mechanisms linking prenatal acetamapamine

exposure to altered brain development.

We have also evaluated the contrary studies that show no association.

...